Paradigm Biocapital Advisors LP CRNX Holdings History
Paradigm Biocapital Advisors LP's Crinetics Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Paradigm Biocapital Advisors LP held 1.95 Mil shares of Crinetics Pharmaceuticals Inc(CRNX), totaling $65.27 Mil. This investment constitutes 2.99% of their stock portfolio, and Paradigm Biocapital Advisors LP now holds 2.08% of the outstanding Crinetics Pharmaceuticals Inc(CRNX) stock.
The initial trade took place in 2022Q3. And since then Paradigm Biocapital Advisors LP has made 9 purchases of CRNX, at an average price of $25.40, for a total of 3.16 Mil shares. In addition, there have been 2 sales at an average price of $51.07 for 1.22 Mil shares. Based on historical transaction data and CRNX's current price of $28.76, Paradigm Biocapital Advisors LP's estimated gain on his CRNX holdings is $37.79 Mil, reflecting a 47.03% gain to date.
Paradigm Biocapital Advisors LP CRNX ($28.76) Holding Chart
Paradigm Biocapital Advisors LP CRNX ($28.76) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
